Antipodes Partners’s Eldorado Gold EGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.2M Buy
1,678,313
+626,171
+60% +$20.4M 0.96% 42
2026
Q1
$36.1M Sell
1,052,142
-613,228
-37% -$25M 0.7% 44
2025
Q4
$59.8M Sell
1,665,370
-608,149
-27% -$18.2M 1.26% 35
2025
Q3
$65.7M Sell
2,273,519
-693,921
-23% -$16.3M 1.47% 29
2025
Q2
$60.4M Sell
2,967,440
-835,455
-22% -$16.3M 1.87% 20
2025
Q1
$64M Buy
3,802,895
+1,152,909
+44% +$17.3M 2% 21
2024
Q4
$39.4M Buy
2,649,986
+2,296,018
+649% +$37.9M 1.37% 26
2024
Q3
$6.15M Buy
+353,968
New +$5.96M 0.21% 46

Other funds holding EGO

Antipodes Partners's EGO Position: Q2 2026 in Review

Antipodes Partners increased its Eldorado Gold (EGO) stake by 60% in Q2 2026, buying an estimated $20.4M and bringing the position to 1,678,313 shares worth $52.2M. The position accounts for 0.96% of the portfolio, ranked #42.

Antipodes Partners first reported a position in EGO in Q3 2024 and has held it in 8 quarters since. The position peaked at $65.7M in Q3 2025. 239 funds tracked by Wall St. Rank hold EGO as of Q2 2026.

  • Antipodes Partners held 1,678,313 shares of Eldorado Gold worth $52.2M as of Q2 2026.
  • Antipodes Partners bought 626,171 Eldorado Gold shares in Q2 2026, an estimated $20.4M.
  • Eldorado Gold made up 0.96% of Antipodes Partners's portfolio in Q2 2026, its #42 holding.
  • Antipodes Partners first reported a position in Eldorado Gold in Q3 2024 and has held it in 8 quarters since.
  • Antipodes Partners's Eldorado Gold position peaked at $65.7M in Q3 2025.
  • 239 funds tracked by Wall St. Rank held Eldorado Gold as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.